TECHWIRE 30
(CIX: WRAL30)  1,102.96  up arrow+11.29  (1.03 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: Apple)  108.00  up arrow+1.02  (0.95 %)  Updated: 06:25 PM EDT, Oct 31 2014
(NY: QUINTILES)  58.54  up arrow+2.24  (3.98 %)  Updated: 06:40 PM EDT, Oct 31 2014
(OP: BASF SE)  88.22  up arrow+1.3  (1.5 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: BioCryst)  11.72  down arrow-0.34  (-2.82 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: BioDelivery)  17.40  down arrow-0.39  (-2.19 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: CEMP)  13.60  down arrow-0.09  (-0.66 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: Cisco Systems)  24.47  up arrow+0.39  (1.62 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: Cree)  31.48  down arrow-0.03  (-0.1 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: DARA)  0.85  down arrow-0.03  (-3.3 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: EMC CORPORATION)  28.73  up arrow+0.27  (0.95 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: Extreme Networks)  3.59  up arrow+0.06  (1.7 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: FB)  74.99  up arrow+0.88  (1.19 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: GLAXOSMITHKLINE)  45.49  up arrow+0.35  (0.78 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: GOOG)  559.08  up arrow+8.77  (1.59 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: IBM)  164.40  up arrow+0.05  (0.03 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NY: LH)  109.29  up arrow+1.9  (1.77 %)  Updated: 06:40 PM EDT, Oct 31 2014
(OP: Lenovo Group)  29.49  down arrow-0.07  (-0.24 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: MRK)  57.94  up arrow+0.63  (1.1 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: Microsoft Corp)  46.95  up arrow+0.9  (1.95 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: NTAP)  42.80  up arrow+0.69  (1.64 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: NOVARTIS AG)  92.69  up arrow+0.74  (0.8 %)  Updated: 06:40 PM EDT, Oct 31 2014
(OP: Novozymes A/S)  46.30  down arrow-0.01  (-0.02 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: PFIZER)  29.95  up arrow+0.11  (0.37 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: Pozen)  9.07  down arrow-0.1  (-1.09 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NY: RED HAT)  58.92  up arrow+0.67  (1.15 %)  Updated: 06:40 PM EDT, Oct 31 2014
(NQ: BBRY)  10.50  up arrow+0.02  (0.19 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: Salix)  143.85  down arrow-0.65  (-0.45 %)  Updated: 05:20 PM EDT, Oct 31 2014
(NQ: SQI)  14.91  down arrow-2.02  (-11.93 %)  Updated: 05:20 PM EDT, Oct 31 2014

Posts tagged “LabCorp”

Updated 8:48 a.m. Wednesday

LabCorp earnings decline; Centice makes big sale; Facebook advertising surges; old Apple brings top dollar; FTC picks privacy expert

Bulldog In today's Bulldog wrapup of tech and life science news: LabCorp's revenue climbs but earnings decline; Centice in RTP makes big sale in drug abuse technology; Facebook's advertising soars; an old Apple sells for a lot of money; and the FTC's new top technologist is a privacy expert.

October 21

Red Hat-SAP mobile deal; Microsoft CEO earns $84M; LabCorp's new HIV test; NC falls to 3rd in biz climate; Honda Aircraft expands

Bulldog In today's Bulldog wrapup of life science and technology news: Red Hat and SAP partner in the cloud; Microsoft's CEO earns $84 million pay package; LabCorp launches new HIV test; North Carolina slips in a business climate survey; and Honda Aircraft keeps growing in the Triad.

October 16

LabCorp-LipoScience deal advances; Red Hat's new women awards; a comet landing; eBay's miss; NetFlix plunge

Bulldog In today's wrapup of tech and life science news: LabCorp's $85M acquisition of LipoScience clears a key hurdle; Red Hat announces women in Open Source awards; a comet landing is at hand; eBay's miss; and NetFlix stock plunges.

September 25

Premium Lock #WTWTrends for Thursday: Red Hat's Bash Bug, Novartis, LabCorp, Sageworks spark social discussions

Trending in the Triangle Trending in the Triangle: Get the pulse of technology in the Triangle with the best in local technology, venture, biotech, and life science news on Thursday as curated by @WRALTechWire.

Updated September 25

Premium Lock LabCorp to acquire Raleigh-based LipoScience in $85M deal

DNA    Lab testing giant LabCorp, which is based in Burlington, is acquiring Triangle-based LipoScience in a deal worth some $85 million in cash. The deal sends LipoScience shares up 60 percent.

April 1

Premium Lock BD reboots startup program; NePhroGenex clinical trial; Red Hat Summit; OxyBio update; LabCorp board shuffle

Bulldog In the latest Bulldog roundup of life science and technology news: BD Technologies re-launches incubator program; NePhroGenex reports a loss for 2013 but secures providers for big clinical trial; Red Hat adds IBM exec to Summit lineup; OxyBio can resume testing; and LabCorp shuffles board.

March 25

Premium Lock Google Glass goes for style; Box plans IPO; nCino, LabCorp name new execs; Disney makes YouTube play

Bulldog The latest Bulldog roundup: Google Glass goes for fashion in deal with Ray-Ban, Oakley; web storage startup Box is going public; cloud banking firm nCino adds a VP for revenue and strategy; LabCorp hires a new CFO; and Disney is buying Maker Studios for $500 million.

February 7

Premium Lock Payment challenges chip at LabCorp revenue as earnings miss

LabCorp LabCorp (NYSE:LH) processed more tests in the fourth quarter than it did same period in the prior year but it made less money per test and the laboratory testing and diagnostics firm's revenue and earnings results fell short of analyst estimates.

Updated January 13

Premium Lock LabCorp launches new genetics-based breast cancer test

Cancer research LabCorp is among the first laboratories offering NanoString Technologies' prognostic breast cancer test, which has been shown in studies to offer better information compared to existing cancer assays.

December 5, 2013

Premium Lock LabCorp breast cancer test faces patent infringement claim from Myriad Genetics

DNA    Myriad Genetics, the company that went all the way to the U.S. Supreme Court seeking patents on human genes, now claims LabCorp's new genetic tests for breast cancer infringe on its patents. Read more about the suit.

October 29, 2013

Premium Lock Former Intersouth exec Garheng Kong joins board at LabCorp

Garheng Kong, a former partner at venture capital firm Intersouth Partners in Durham, is the newest member of the board at lab testing giant LabCorp.

Garheng Kong Garheng Kong

October 18, 2013

Premium Lock LabCorp CFO Hayes to retire in 2014

LabCorp After 17 years at LabCorp, CFO Brad Hayes plans to retire from the laboratory testing and diagnostics company next year.

August 8, 2013

Premium Lock LabCorp laying off 200 in California

LabCorp The layoffs affect workers at LabCorp locations in Irvine, Calif. and Los Angeles.

July 19, 2013

Premium Lock Higher costs cut into LabCorp's 2Q profit

LabCorp Despite posting revenue gains, LabCorp's profit was hurt by rising costs.

April 19, 2013

Premium Lock LabCorp's earnings, revenue fall shy of analyst estimates

LabCorp LabCorp said that margins were negatively affected by weather, Medicare payment reductions and the number of days in the quarter.

Updated April 2, 2013

Premium Lock LabCorp lands five-year biomarker test deal with Squibb

LabCorp The lab testing giant signs a contract for services and biomarker testing with Bristol-Myers Squibb. LabCorp also says it is expanding tests related to inflammatory bowel disease.

February 8, 2013

Premium Lock LabCorp launching $1B share buyback program

LabCorp LabCorp, the lab testing giant, said Friday it is launching a $1 billion share buyback program.

October 12, 2012

Premium Lock Former LabCorp CEO, chairman to retire from board

LabCorp Thomas Mac Mahon, chief executive officer at LabCorp for a decade who then became the firm;s chairman, is retiring from the board of directors.

August 21, 2012

Premium Lock LabCorp plans to sell $1 billion in bonds

LabCorp The lab testing firm, which earlier this month was the subject of leveraged buyout rumors on Wall Street, is selling bonds in two $500 million packages.

Updated August 2, 2012

Premium Lock LabCorp denies any knowledge of a possible buyout

LabCorp The lab testing firm, which is based in Burlington, says it is "aware" of possible buyout talk but says it's "not in current discussions."

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll